Scrip Regulatory Affairs
GAO finds gaps in the US FDA medical device recall procedures
23 June 2011
Vibha Sharma
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- US bill asks FDA to issue final UDI rule by 2012-end and expand Sentinel monitoring to devices
- US HHS misses implementation deadline for transparency provision; drug, device firms concerned
- Australian Senate panel inquiry expresses shock at patient experiences with DePuy hip devices; calls for stricter regulations
- US FDA overall device review time up by 61%, says GAO report
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
